Linfoma. IPO Porto já usou imunoterapia inovadora

from E=mc² · host Observador

Equipa foi convidada a participar num teste internacional com imunoterapia de células CAR-T para tratar mielomas. Mário Mariz, diretor da Clínica de Hemato-Oncologia do IPO Porto, faz o balanço.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Feb 10, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Linfoma. IPO Porto já usou imunoterapia inovadora

0:00 12:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of E=mc²?

This episode is 12 minutes long.

When was this E=mc² episode published?

This episode was published on February 10, 2022.

Can I download this E=mc² episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!